AGUZZI, Chiara
AGUZZI, Chiara
Dip. MEDICINA ED ONCOLOGIA SPERIMENTALE (attivo dal 01/01/1900 al 30/04/2013)
How many patients can proceed from chronic myeloid leukaemia diagnosis to deep molecular response and long-lasting imatinib discontinuation? A real life experience
2017-01-01 Ferrero, D; Cerrano, M; Crisà, E; Aguzzi, C; Giai, V; Boccadoro, M.
IMATINIB DISCOTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON 28 UNSELECTED PATIENTS
2014-01-01 Cerrano, M; Fava, C; Pregno, P; Giai, V; Nicolosi, M; Aguzzi, C; Dogliotti, I; Rege-Cambrin, G; Boccadoro, M; Vitolo, U; Saglio, G; Ferrero, D
Long-term therapy-free remission in a patient with platelet-derived growth factor receptor beta-rearranged myeloproliferative neoplasm.
2016-01-01 Cerrano, M; Crisà, E; Gottardi, E; Aguzzi, C; Boccadoro, M; Ferrero, D.
Prognostic value of JAK2V617F, CALR and MPL mutational status on outcome and thrombotic risk in a retrospective cohort of 138 patients with Essential THrombocythemia
2014-01-01 Benevolo, G.; Riera, L.; Nicolino, B.; Evangelista, A.; Beggiato, E.; Aguzzi, C.; Nicolosi, M.; Frairia, C.; Vitolo, U
Retrospective analysis of 260 patients with essential thrombocythemia: iwg-mrt (ipset model; passamonti et al, blood 2012) prognostic score is a good predictor of survival
2014-01-01 Benevolo, G.; Nicolino, B.; Beggiato, E.; Frairia, C.; Evangelista, A.; Pirillo, F.; Manzini, Pm.; Riera, L.; Aguzzi, C.; Vitolo, U
Treatment-free remission in chronic myeloid leukemia harboring atypical BCRABL1 transcripts
2020-01-01 Dragani M.; Petiti J.; Rege-Cambrin G.; Gottardi E.; Daraio F.; Caocci G.; Aguzzi C.; Crisa E.; Andreani G.; Caciolli F.; Fava C.